Dermatological Adverse Events with Taxane Chemotherapy

    September 2016 in “ European Journal of Dermatology ”
    V. Sibaud, Nicole R. LeBoeuf, Henri Roché … Mario E. Lacouture
    Studysummary This review examines dermatological side effects of taxane chemotherapy reported in past studies and highlights the necessity for identifying and managing these conditions to maintain cancer patients' quality of life; it presents no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on europepmc.org →
    Discuss this study in the Community →

    Research cited in this study 16

    1. Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss Journal of Investigative Dermatology Symposium Proceedings · 2013
    2. Alopecia With Endocrine Therapies in Patients With Cancer Oncologist · 2013
    3. Efficacy and Tolerability of Two Scalp Cooling Systems for the Prevention of Alopecia Associated with Docetaxel Treatment Supportive Care in Cancer · 2013
    4. Docetaxel and Permanent Alopecia Journal of The American Academy of Dermatology · 2013
    5. Pathobiology of Chemotherapy-Induced Hair Loss The Lancet Oncology · 2013
    6. Permanent Scalp Alopecia Related to Breast Cancer Chemotherapy by Sequential Fluorouracil/Epirubicin/Cyclophosphamide (FEC) and Docetaxel: A Prospective Study of 20 Patients Annals of Oncology · 2012
    7. Treatment of Chemotherapy-Induced Alopecia Dermatologic Therapy · 2011
    8. Permanent Alopecia After Systemic Chemotherapy: A Clinicopathological Study of 10 Cases The American Journal of Dermatopathology · 2011
    9. Chemotherapy-Induced Hair Loss PubMed · 2010
    10. Permanent Chemotherapy-Induced Alopecia: Case Report and Review of the Literature Journal of The American Academy of Dermatology · 2010
    11. Irreversible And Severe Alopecia Following Docetaxel Or Paclitaxel Cytotoxic Therapy For Breast Cancer British journal of dermatology/British journal of dermatology, Supplement · 2009
    12. Chemotherapy-Induced Anagen Effluvium: Diffuse or Patterned? Dermatology · 2007
    13. Cutaneous Toxicities of Cancer Therapy Current opinion in oncology/Current opinion in oncology, with cancerlit · 2002
    14. Cutaneous Reactions to Chemotherapeutic Agents ˜The œAmerican journal of the medical sciences · 2001
    15. Mucocutaneous Reactions to Chemotherapy Journal of The American Academy of Dermatology · 1999
    16. Docetaxel Journal of clinical oncology · 1995